Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Chemico-Biological Interactions
|
January 15, 2019
Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line
Dhanaraj Teekaraman, Sugantha Priya Elayapillai, Mangala Priya Viswanathan, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie
|
July 26, 2017
Ameliorative effect of α-tocopherol on polychlorinated biphenyl (PCBs) induced testicular Sertoli cell dysfunction in F<sub>1</sub> prepuberal rats
Sugantha Priya Elayapillai, Dhanaraj Teekaraman, Raja Singh Paulraj, et al.
Breast Cancer Research : BCR
|
January 31, 2026
Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ
Cole Hladik, Sugantha Priya Elayapillai, Samrita Dogra, et al.
Gynecologic Oncology
|
October 20, 2024
ATR inhibition increases reliance on PARP-mediated DNA repair revealing an improved therapeutic strategy for cervical cancer
Sugantha Priya Elayapillai, Samrita Dogra, James Lausen, et al.
Cancer Letters
|
October 14, 2023
Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer
Samrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer
Sugantha Priya Elayapillai, Anjalika Gandhi, Samrita Dogra, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 19, 2024
<b> </b>
Sugantha Priya Elayapillai, Anjalika Gandhi, Samrita Dogra, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 29, 2026
DCLK1 regulates stemness and IL-6/STAT3-dependent metastatic niche formation in chemoresistant ovarian cancer
Samrita Dogra, Sugantha Priya Elayapillai, Cole Hladik, et al.
Cancer Letters
|
July 3, 2025
Corrigendum to "Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer" [Cancer Lett. 2023 Dec 1;578:216437]
Samrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
Cancer Letters
|
May 19, 2025
Preferential release of microRNAs via extracellular vesicles is associated with ductal carcinoma in situ to invasive breast cancer progression
Sugantha Priya Elayapillai, Samrita Dogra, Cole Hladik, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Chemico-Biological Interactions
|
January 15, 2019
Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line
Dhanaraj Teekaraman, Sugantha Priya Elayapillai, Mangala Priya Viswanathan, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie
|
July 26, 2017
Ameliorative effect of α-tocopherol on polychlorinated biphenyl (PCBs) induced testicular Sertoli cell dysfunction in F<sub>1</sub> prepuberal rats
Sugantha Priya Elayapillai, Dhanaraj Teekaraman, Raja Singh Paulraj, et al.
Breast Cancer Research : BCR
|
January 31, 2026
Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ
Cole Hladik, Sugantha Priya Elayapillai, Samrita Dogra, et al.
Gynecologic Oncology
|
October 20, 2024
ATR inhibition increases reliance on PARP-mediated DNA repair revealing an improved therapeutic strategy for cervical cancer
Sugantha Priya Elayapillai, Samrita Dogra, James Lausen, et al.
Cancer Letters
|
October 14, 2023
Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer
Samrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer
Sugantha Priya Elayapillai, Anjalika Gandhi, Samrita Dogra, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 19, 2024
<b> </b>
Sugantha Priya Elayapillai, Anjalika Gandhi, Samrita Dogra, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 29, 2026
DCLK1 regulates stemness and IL-6/STAT3-dependent metastatic niche formation in chemoresistant ovarian cancer
Samrita Dogra, Sugantha Priya Elayapillai, Cole Hladik, et al.
Cancer Letters
|
July 3, 2025
Corrigendum to "Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer" [Cancer Lett. 2023 Dec 1;578:216437]
Samrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
Cancer Letters
|
May 19, 2025
Preferential release of microRNAs via extracellular vesicles is associated with ductal carcinoma in situ to invasive breast cancer progression
Sugantha Priya Elayapillai, Samrita Dogra, Cole Hladik, et al.
Page
of 2